Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). (Q51719313)
Jump to navigation
Jump to search
scientific article published on 4 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). |
scientific article published on 4 June 2014 |
Statements
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) (English)
A Ruzsa
M Sen
M Evans
L W Lee
K Hideghety
S Rottey
P Klimak
J Fayette
T Csoszi
J Erfan
U Forssmann
T Goddemeier
A Bexon
C Nutting
NA EMD 1201081 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference